Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

NCT ID: NCT05174169

This clinical trial, titled "Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease," is looking at how to best choose chemotherapy treatments for patients with Stage III colon cancer ...

Recruiting

Phase: PHASE2 Conditions: Stage III Colon Cancer

A Study of S-892216 in Participants With COVID-19

NCT ID: NCT06928051

This clinical trial is studying a new medication called S-892216 to see how well it can help people with COVID-19, which is caused by the virus SARS-CoV-2. The main goal is to find out if this medi...

Recruiting

Phase: PHASE2 Conditions: COVID-19

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)

NCT ID: NCT06455202

This clinical trial is studying a new treatment called barzolvolimab for adults suffering from Chronic Spontaneous Urticaria (CSU), which is a condition where people experience itchy hives without ...

Recruiting

Phase: PHASE3 Conditions: Chronic Spontaneous Urticaria

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

NCT ID: NCT02523014

This clinical trial is investigating the effectiveness of four different medications—vismodegib, GSK2256098 (a FAK inhibitor), capivasertib, and abemaciclib—in treating patients with progressive me...

Recruiting

Phase: PHASE2 Conditions: Intracranial Meningioma, Recurrent Meningioma +1 more

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

NCT ID: NCT03609216

This clinical trial is looking at how well two chemotherapy drugs, gemcitabine and cisplatin, work for treating patients with a type of bladder cancer called muscle-invasive urothelial carcinoma. T...

Recruiting

Phase: PHASE2 Conditions: Infiltrating Bladder Urothelial Carcinoma, Stage II Bladder Urothelial Carcinoma +1 more

Genetic Testing in Guiding Treatment for Patients With Brain Metastases

NCT ID: NCT03994796

This clinical trial is exploring how genetic testing can help doctors choose the best treatments for patients with solid tumors that have spread to the brain. Researchers are particularly intereste...

Recruiting

Phase: PHASE2 Conditions: Metastatic Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Brain +5 more

Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

NCT ID: NCT04242095

**Trial Summary: Collection of Research Data and Samples from Patients Experiencing Immunotherapy Side Effects** This clinical trial is focused on gathering information and samples from patients w...

Recruiting

Conditions: Malignancy

A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo

NCT ID: NCT06625177

This clinical trial is testing a new treatment called TEV-53408 for people with vitiligo, a condition that causes skin to lose its color. The main goals of the trial are to see if TEV-53408 is safe...

Recruiting

Phase: PHASE1 Conditions: Vitiligo

Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

NCT ID: NCT05382299

This clinical trial is studying a new treatment called sacituzumab govitecan-hziy (SG) for patients with locally advanced or metastatic triple-negative breast cancer (TNBC) that has not been treate...

Recruiting

Phase: PHASE3 Conditions: Triple Negative Breast Cancer, PD-L1 Negative

S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer

NCT ID: NCT03418961

This clinical trial, called S1501, is investigating whether a medication called carvedilol can help prevent heart problems in patients with metastatic HER-2-positive breast cancer. This type of can...

Recruiting

Phase: PHASE3 Conditions: Recurrent Breast Carcinoma, Cardiotoxicity +3 more

A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

NCT ID: NCT06873945

This clinical trial is studying a medication called ritlecitinib to see how safe and effective it is for treating alopecia areata, a condition that causes significant hair loss on the scalp and oth...

Recruiting

Phase: PHASE3 Conditions: Alopecia Areata

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

NCT ID: NCT06767514

This clinical trial is studying a new treatment called ivonescimab for adults with metastatic non-small cell lung cancer (NSCLC) who have a specific marker known as high PD-L1 expression. The trial...

Recruiting

Phase: PHASE3 Conditions: Non-Small Cell Lung Cancer

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

NCT ID: NCT06018428

The SIGNAL-AA trial is studying a new treatment called bempikibart (ADX-914) for people with severe alopecia areata, a condition that causes significant hair loss. This trial is split into two part...

Recruiting

Phase: PHASE2 Conditions: Alopecia Areata

A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

NCT ID: NCT06550076

This clinical trial is studying a new medication called TAK-279 to see how well it works and how safe it is for people with moderate-to-severe plaque psoriasis, a skin condition that causes red, fl...

Recruiting

Phase: PHASE3 Conditions: Plaque Psoriasis

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

NCT ID: NCT03723928

The S1703 clinical trial is looking at a new way to monitor patients with hormone receptor-positive, HER2-negative metastatic breast cancer, which means the cancer has spread to other parts of the ...

Recruiting

Phase: NA Conditions: Anatomic Stage IV Breast Cancer AJCC v8, HER2/Neu Negative +4 more

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

NCT ID: NCT03228667

The QUILT-3.055 clinical trial is studying new combination treatments for patients with advanced solid tumors, such as lung, kidney, and skin cancers, who have not responded to previous immune ther...

Recruiting

Phase: PHASE2 Conditions: Colorectal Cancer, Hepatocellular Carcinoma +11 more

T-DM1 and Tucatinib Compared with T-DM1 Alone in Preventing Relapses in People with High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

NCT ID: NCT04457596

The CompassHER2 RD Trial is studying how well a combination of two medications, T-DM1 and tucatinib, works to prevent breast cancer from coming back in people at high risk for HER2-positive breast ...

Recruiting

Phase: PHASE3 Conditions: Invasive Breast Carcinoma, HER2 Positive Breast Carcinoma +20 more

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

NCT ID: NCT05059444

The ORACLE trial is investigating a new blood test developed by Guardant Health that looks for small pieces of cancer DNA in the blood, known as ctDNA, in patients who have been treated for early-s...

Recruiting

Conditions: Non-small Cell Lung Cancer, Renal Cell Carcinoma +14 more

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

NCT ID: NCT05254171

This clinical trial is looking at a combination treatment for patients with metastatic pancreatic cancer, specifically using two standard drugs called nab-paclitaxel and gemcitabine, with or withou...

Recruiting

Phase: PHASE2 Conditions: Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Metastatic +1 more

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

NCT ID: NCT05108298

This clinical trial is focused on improving how young adults and adolescents with cancer report their experiences and symptoms during treatment. The study aims to find out if giving participants a ...

Recruiting

Phase: NA Conditions: Melanoma, Breast Cancer, NOS +10 more

Main Menu

Clinical Trials in Hot Springs, Arkansas

48 Active Trials Found in Hot Springs

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

A Study of S-892216 in Participants With COVID-19

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Genetic Testing in Guiding Treatment for Patients With Brain Metastases

Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo

Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer

A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

T-DM1 and Tucatinib Compared with T-DM1 Alone in Preventing Relapses in People with High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials